DevicePharm is excited to present Medical Alley’s 2018 Annual Meeting on April 24th. The meeting, which is comprised of industry executives from across many healthcare-focused sectors, is celebrating Minnesota as the global epicenter of health innovation and care.
To support Abbot’s DTC initiative, we developed a new landing page about the Confirm Rx Insertable Cardiac Monitor (ICM) that includes information on the symptoms of an irregular heartbeat, Atrial Fibrillation, and how Confirm Rx could help confirm their diagnosis.
On February 15, 2018, DevicePharm will participate with other medical device leaders in the “TMDA Quarterly Meeting”. The meeting focus is: Developing a Winning Strategy. The meeting will be held between 2pm and 4pm at Norris Conference Center, 2525 West Anderson Lane, Suite 365, Austin, TX.
On June 6, 2017, DevicePharm was honored to make the opening presentation at the 2017 Spring BioBash in Austin, Texas. The presentation was titled, “So You’re Going To Launch”. It was presented to provide a guide for med-tech executives, marketers, and entrepreneurs who are launching new products, companies, and markets.
DevicePharm, a marketing strategy and integrated marketing solutions firm, was awarded two 2016 International Davey Awards this month for work created on behalf of Bausch + Lomb’s VICTUS® Femtosecond Laser Platform brand and Clarity Medical’s HOLOS IntraOp™ brand.
SkylineDx debuted its new MMprofiler™ with SKY92 campaign this year during the European Hematology Association conference in Denmark. MMprofiler with SKY92 enables physicians to quickly and confidently identify high-risk multiple myeloma patients.
DevicePharm has been recognized as a Foundational Member of Medical Alley, the Minnesota-based organization focused on growing one of the world’s most prolific centers of healthcare technology and delivery innovation.
UK Trade & Investment — the business development arm of the British Consulate — invited DevicePharm CEO & Chief Strategy Officer, Clay Wilemon, to present to UK medical firms during a February conference.
Healthcare reform is changing the way that healthcare marketers think about everything from clinical trials to product launches. New payment models, new delivery models, and HEOR mandates are all creating major changes in marketing focus for medical device, biotech, pharmaceutical, and medical diagnostics companies.
At the 2015 San Antonio Breast Cancer Symposium, Provista introduced Videssa® Breast, a breakthrough that accurately detects the presence or absence of breast cancer with a protein-based blood test. Videssa® Breast provides clinicians, and their patients, with clinical confidence, clarity and peace-of-mind about what to do next when mammography is unclear – detecting the absence or presence of breast cancer by identifying early warning signals called biomarkers.